<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39349781</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-160X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Rheumatology international</Title><ISOAbbreviation>Rheumatol Int</ISOAbbreviation></Journal><ArticleTitle>Changes in the cytotoxic and regulatory functions of NK cells in patients with long-COVID under the influence of the human herpesvirus 6 (pilot study).</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-024-05677-3</ELocationID><Abstract><AbstractText>Long-COVID are often accompanied by the development of autoimmun disorders. Such dysregulation of the immune system can be caused by reactivation of "sluggish" herpesvirus infection in patients after COVID-19. The one of the possible causes of autoimmunization is a change in the cytotoxic functions of NK cells under the influence of HHV6. The aim of research was to study the expression of receptor-ligand Fas-FasL, regulating marker CD38 and inhibitory receptor TIM-3 on NK cells in patients with long-COVID after mild, moderate, and severe stage of COVID-19 in the anamnesis with or without reactivation of HHV-6 and to identify risk factors for the formation of autoimmune disorders in these patients. This study investigated 124 adults (73 female and 51 male) aged 18 to 65&#xa0;years with long-COVID. The groups of patients with long-COVID were divided depending on mild, moderate, and severe forms of COVID-19 in the anamnesis and with/without reactivation of HHV-6. The control group included 20 healthy participants. Molecular genetic studies (PCR) were performed for all patients to detect the existence of DNA HHV6. Multiparametric flow cytometry was performed on 124 EDTA peripheral blood samples collected from long-COVID patients and 20 healthy controls. There was defined an imbalance between acute antiviral mechanisms, the response contributing to tissue damage and immunopathology, probably autoimmunity in patients with long-COVID after different forms of COVID-19 with reactivation of HHV-6. The presence of HHV-6 in groups with long-COVID was accompanied by higher expression of FasL and CD38, especially in patients, who had a severe form of COVID-19 in the anamnesis. The decrease in TIM-3 in patients with reactivation of HHV-6 compared to patients without HHV-6 puts the preservation of immunological tolerance at risk of Th1-dependent immune responses. The reactivation of HHV-6 is accompanied by higher expression of FasL and CD38, which indicates increased hyperactivation of NK cells, their cytotoxic activity, and subsequent exhaustion. NK cells of these patients lose their immunoregulatory ability, this creates prerequisites for the development of immunopathology, probably autoimmune processes.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zubchenko</LastName><ForeName>Svitlana</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4471-4884</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. svitlana_zu@meta.ua.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Havrylyuk</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9808-8896</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kril</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-6728-5827</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadishko</LastName><ForeName>Olena</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-4656-9481</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolinkovskyi</LastName><ForeName>Oleksandr</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-1163-1882</Identifier><AffiliationInfo><Affiliation>Department of hygiene and prophylactic toxicology FPDO of Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chopyak</LastName><ForeName>Valentyna</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3127-2028</Identifier><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Rheumatol Int</MedlineTA><NlmUniqueID>8206885</NlmUniqueID><ISSNLinking>0172-8172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune disease</Keyword><Keyword MajorTopicYN="N">Exhaustion of cells</Keyword><Keyword MajorTopicYN="N">Human herpesvirus 6</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">NK cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39349781</ArticleId><ArticleId IdType="doi">10.1007/s00296-024-05677-3</ArticleId><ArticleId IdType="pii">10.1007/s00296-024-05677-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. A clinical case definition of post-COVID-19 condition by a Delphi consensus (2021) www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 . Accessed 6 Oct 2021</Citation></Reference><Reference><Citation>Cutler DM (2022) The costs of long COVID. JAMA Health Forum 3(5):e221809. https://doi.org/10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S (2022) Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr 181:1597&#x2013;1607. https://doi.org/10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId><ArticleId IdType="pmc">8742700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J et al (2021) Multi-organ impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 11:e048391. https://doi.org/10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O et al (2022) Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int 42:1523&#x2013;1530. https://doi.org/10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId><ArticleId IdType="pmc">9159383</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J-M, Herr&#xe1;n M, Beltr&#xe1;n S, Rojas M (2022) Is post-COVID syndrome an autoimmune disease? Expert Rev Clin Immunol 18(7):653&#x2013;666. https://doi.org/10.1080/1744666X.2022.2085561</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2022.2085561</ArticleId><ArticleId IdType="pubmed">35658801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40(7):2611&#x2013;2619. https://doi.org/10.1007/s10067-021-05691-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05691-x</ArticleId><ArticleId IdType="pubmed">33733315</ArticleId><ArticleId IdType="pmc">7968918</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P (2020) Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol 41(12):1100&#x2013;1115. https://doi.org/10.1016/j.it.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId><ArticleId IdType="pmc">7556779</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleki K, Shirzad M, Javanian M et al (2022) Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. Front Immunol 13:947401. https://doi.org/10.3389/fimmu.2022.947401</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.947401</ArticleId><ArticleId IdType="pubmed">36119078</ArticleId><ArticleId IdType="pmc">9471328</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE et al (2021) Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection. JAMA Netw Open 4(10):e2128568. https://doi.org/10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId><ArticleId IdType="pmc">8515212</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE: COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. https://www.nice.org.uk/guidance/ng188 . Accessed 18 Dec 2020</Citation></Reference><Reference><Citation>Yang Y, Day J, Guimaraes FS-F et al (2021) Natural killer cells in inflammatory autoimmune diseases. Clin Transl Immunol 19:e1250. https://doi.org/10.1002/cti2.1250www.wileyonlinelibrary.com/journal/cti</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1250www.wileyonlinelibrary.com/journal/cti</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W-J, Wang F-S, Song J-W (2023) Characteristics and potential roles of natural killer cells during SARS-CoV-2 infection. Infect Dis Immun 3(1):29&#x2013;35. https://doi.org/10.1097/ID9.0000000000000075</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ID9.0000000000000075</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo R, Bortolotti D, Gentili V et al (2019) KIR2DS2/KIR2DL2/HLA-C1 haplotype is associated with Alzheimer&#x2019;s disease: implication for the role of herpesvirus infections. J Alzheimers Dis 67:1379&#x2013;1389. https://doi.org/10.3233/JAD180777</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD180777</ArticleId><ArticleId IdType="pubmed">30689576</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodridge JP, &#xd6;nfelt B, Malmberg KJ (2015) Newtonian cell interactions shape natural killer cell education. Immunol Rev 267(1):197&#x2013;213. https://doi.org/10.1111/imr.12325</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12325</ArticleId><ArticleId IdType="pubmed">26284479</ArticleId><ArticleId IdType="pmc">4832384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Cao K, Liu S et al (2022) TIM-3 expression causes NK cell dysfunction in type 2 diabetes patients. Front Immunol 13:852436. https://doi.org/10.3389/fimmu.2022.852436</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.852436</ArticleId><ArticleId IdType="pubmed">35464400</ArticleId><ArticleId IdType="pmc">9018664</ArticleId></ArticleIdList></Reference><Reference><Citation>Horenstein AL, Faini AC, Malavasi F (2021) CD38 in the age of COVID-19: a medical perspective. Physiol Rev 101(4):1457&#x2013;1486. https://doi.org/10.1152/physrev.00046.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00046.2020</ArticleId><ArticleId IdType="pubmed">33787351</ArticleId><ArticleId IdType="pmc">8313238</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2023) Clinical management of COVID-19: living guideline, 18 August 2023. World Health Organization. License: CC BYNC-SA 3.0 IGO. https://iris.who.int/handle/10665/372288 . Accessed 18 Aug 2023</Citation></Reference><Reference><Citation>Maucourant C, Filipovic I, Ponzetta A, COVID-19 Study Group et al (2020) Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol 5(50):eabd832. https://doi.org/10.1126/sciimmunol.abd6832</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6832</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzi T, L&#xfc;nemann A, Murer A et al (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124:2533&#x2013;2543. https://doi.org/10.1182/blood-2014-01-553024</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-01-553024</ArticleId><ArticleId IdType="pubmed">25205117</ArticleId><ArticleId IdType="pmc">4199955</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliassen E, Di Luca D, Rizzo R et al (2017) The interplay between natural killer cells and human herpesvirus-6. Viruses 9(12):367&#x2013;375. https://doi.org/10.3390/v9120367</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9120367</ArticleId><ArticleId IdType="pubmed">29194419</ArticleId><ArticleId IdType="pmc">5744142</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R, Soffritti I, D&#x2019;Accolti M et al (2017) HHV-6A/6B infection of NK cells modulates the expression of miRNAs and transcription factors potentially associated with impaired NK activity. Front Microbiol 8:2143. https://doi.org/10.3389/fmicb.2017.02143</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02143</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nz C (2018) Human &#x3b3;-herpesvirus infection, tumorigenesis, and immune control in mice with reconstituted human immune system components. Front Immunol 9:1&#x2013;5. https://doi.org/10.3389/fimmu.2018.00238</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00238</ArticleId></ArticleIdList></Reference><Reference><Citation>Almine JF, O&#x2019;hare CA, Dunphy G et al (2017) IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. Nat Commun 8:14392. https://doi.org/10.1038/ncomms14392</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14392</ArticleId><ArticleId IdType="pubmed">28194029</ArticleId><ArticleId IdType="pmc">5316833</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyzowska M, Kowalczyk A, Skulska K (2021) Fas/FasL contributes to HSV1 brain infection and neuroinflammation. Front Immunol 12:1&#x2013;5. https://doi.org/10.3389/fimmu.2021.714821</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.714821</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Roche M, Asano Y, Griffiths GM (2016) Origins of the cytolytic synapse. Nature Rev Immunol 16:421&#x2013;432. https://doi.org/10.1038/nri.2016.54</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.54</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada A, Arakaki R, Saito M et al (2017) Dual role of Fas/FasL-mediated signal in peripheral immune tolerance. Front Immunol 8:1&#x2013;6. https://doi.org/10.3389/fimmu.2017.00403</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00403</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester JV, McMenamin PG, Dando SJ (2018) CNS infection and immune privilege. Nat Rev Neurosci 19:655&#x2013;671. https://doi.org/10.1038/s41583-018-0070-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0070-8</ArticleId><ArticleId IdType="pubmed">30310148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkstr&#xf6;m NK, Strunz B, Ljunggren H-G (2022) Natural killer cells in antiviral immunity. Nat Rev Immunol 22:112&#x2013;124. https://doi.org/10.1038/s41577-021-00558-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00558-3</ArticleId><ArticleId IdType="pubmed">34117484</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Sun Y, Yang Z et al (2022) Calcium ions signaling: targets for attack and utilization by viruses. Front Microbiol 13:889374. https://doi.org/10.3389/fmicb.2022.889374</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.889374</ArticleId><ArticleId IdType="pubmed">35859744</ArticleId><ArticleId IdType="pmc">9289559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh WC, Lai EY, Liu YT et al (2021) NK cell receptor and ligand composition influence the clearance of SARS-CoV-2. J Clin Invest 131(21):e146408. https://doi.org/10.1172/jci146408</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci146408</ArticleId><ArticleId IdType="pubmed">34720095</ArticleId><ArticleId IdType="pmc">8553551</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Nadizhko O, Kril I, Havrylyuk A, Bakun O-N, Chopyak V (2024) Proceedings of the Shevchenko Scientific Society. Med Sci 1:(73). https://doi.org/10.25040/ntsh</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>